AI Article Synopsis
- The SARS-CoV-2 coronavirus has caused a worldwide pandemic, resulting in over 250,000 deaths since December 2019 and severely impacting both business and cancer research.
- Researchers in oncology are encouraged to actively engage in diagnosing and treating patients infected with SARS-CoV-2.
- The involvement of cancer researchers is crucial not only for managing the pandemic but also for minimizing its effects on cancer research and patient care.
Article Abstract
The coronavirus SARS-CoV-2 has created a global pandemic that has killed more than a quarter million people since December 2019, halted commerce, and disrupted our ability to research cancer in the laboratory and clinic and care for our patients. A return to a functioning society can be facilitated by the active participation of cancer researchers to diagnose and treat SARS-CoV-2-infected patients, and the direct and indirect benefits of our involvement cannot be overstated.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/2159-8290.CD-20-0657 | DOI Listing |
Publication Analysis
Top Keywords
era covid-19
4
covid-19 rise
4
rise science
4
science collectivism
4
collectivism cancer
4
cancer coronavirus
4
coronavirus sars-cov-2
4
sars-cov-2 created
4
created global
4
global pandemic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!